{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:39:16Z","timestamp":1769603956767,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"crossref","award":["31M082"],"award-info":[{"award-number":["31M082"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Polish National Science Center","award":["31M126"],"award-info":[{"award-number":["31M126"]}]},{"name":"Polish National Science Center","award":["DEC-2011\/02\/A\/NZ4\/00031"],"award-info":[{"award-number":["DEC-2011\/02\/A\/NZ4\/00031"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.physbeh.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T04:28:13Z","timestamp":1436588893000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1328-495X","authenticated-orcid":false,"given":"Amine","family":"Bahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed M.","family":"Nurulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"\u0141a\u017cewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2015.07.012_bb0005","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00213-010-2092-4","article-title":"JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats","volume":"214","author":"Galici","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00213-009-1710-5","article-title":"Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice","volume":"208","author":"Nuutinen","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0015","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neuropharm.2010.10.027","article-title":"Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA\/2J mice","volume":"60","author":"Nuutinen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0020","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00213-014-3751-7","article-title":"Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs","volume":"232","author":"Vanhanen","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bph.12170","article-title":"Histamine is required for H(3) receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation","volume":"170","author":"Vanhanen","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-013-3019-7","article-title":"Influence of the novel histamine H(3) receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice","volume":"228","author":"Bahi","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0035","doi-asserted-by":"crossref","unstructured":"Alakarppa, K., Tupala, E., Mantere, T., Sarkioja, T., Rasanen, P., Tarhanen, J., et al. Effect of alcohol abuse on human brain histamine and tele-methylhistamine. Inflamm. Res. 2002,51 Suppl 1:S40-1.","DOI":"10.1007\/PL00022438"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbr.2012.09.025","article-title":"Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders","volume":"237","author":"Alleva","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-008-1345-y","article-title":"Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions","volume":"202","author":"Brabant","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","article-title":"Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse","volume":"259","author":"Clapham","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2741\/s279","article-title":"Histamine receptor subtypes: a century of rational drug design","volume":"4","author":"Walter","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0060","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","article-title":"Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat","volume":"22","author":"Pillot","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0065","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0070","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4522(87)90279-X","article-title":"Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors","volume":"23","author":"Arrang","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","article-title":"Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function","volume":"55","author":"Ferrada","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0085","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bcp.2007.01.006","article-title":"Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions","volume":"73","author":"Humbert-Claude","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0090","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1074\/jbc.M110.161489","article-title":"Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway","volume":"286","author":"Moreno","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cns.12279","article-title":"Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities","volume":"20","author":"Nikolic","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/138161211796197133","article-title":"Histamine H(3) receptor (H(3)R) antagonists and inverse agonists in the treatment of sleep disorders","volume":"17","author":"Broderick","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2174\/156802611795860906","article-title":"The histamine H(3) receptor as a therapeutic drug target for metabolic disorders: status, challenges and opportunities","volume":"11","author":"Plancher","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0110","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1248\/bpb.31.2163","article-title":"Histamine H3 receptor antagonists go to clinics","volume":"31","author":"Sander","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/13543776.2014.848197","article-title":"New developments around histamine H(3) receptor antagonists\/inverse agonists: a patent review (2010\u2013present)","volume":"24","author":"Lazewska","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0125","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1476-5381.2012.02093.x","article-title":"Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives","volume":"167","author":"Bhowmik","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0130","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.bmc.2006.01.013","article-title":"Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists","volume":"14","author":"Lazewska","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pbb.2012.01.008","article-title":"The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice","volume":"101","author":"Bahi","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/10253890.2012.754419","article-title":"Increased anxiety, voluntary alcohol consumption and ethanol-induced place preference in mice following chronic psychosocial stress","volume":"16","author":"Bahi","year":"2013","journal-title":"Stress (Amsterdam, Netherlands)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2013.01.023","article-title":"Individual differences in elevated plus-maze exploration predicted higher ethanol consumption and preference in outbred mice","volume":"105","author":"Bahi","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0091-3057(02)00745-1","article-title":"Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model","volume":"72","author":"Fox","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0155","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1016\/j.bmcl.2013.06.075","article-title":"Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol","volume":"23","author":"Sadek","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/FBP.0000000000000042","article-title":"Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists","volume":"25","author":"Sadek","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2014.03.014","article-title":"Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties","volume":"77","author":"Sadek","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0170","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/npp.2012.122","article-title":"Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats","volume":"38","author":"Bahi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-011-2630-8","article-title":"Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice","volume":"222","author":"Bahi","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbr.2011.09.024","article-title":"Involvement of tissue plasminogen activator \u201ctPA\u201d in ethanol-induced locomotor sensitization and conditioned-place preference","volume":"226","author":"Bahi","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0185","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1111\/ejn.12228","article-title":"Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption","volume":"38","author":"Bahi","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-013-3243-1","article-title":"Chronic psychosocial stress causes delayed extinction and exacerbates reinstatement of ethanol-induced conditioned place preference in mice","volume":"231","author":"Bahi","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.peptides.2013.02.008","article-title":"Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference","volume":"43","author":"Bahi","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002130050694","article-title":"The discriminative stimulus effects of ethanol are mediated by NMDA and GABA(A) receptors in specific limbic brain regions","volume":"139","author":"Hodge","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/BF02007768","article-title":"Modulation of morphine-induced antinociception in mice by histamine H3-receptor ligands","volume":"41","author":"Owen","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000191473","article-title":"Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys","volume":"83","author":"Banks","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(98)00789-4","article-title":"Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats","volume":"363","author":"Munzar","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2007.04.051","article-title":"Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task","volume":"569","author":"Kholdebarin","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.09024FP","article-title":"Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice","volume":"111","author":"Okuda","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0230","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1096\/fj.00-0545fje","article-title":"Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms","volume":"15","author":"Lintunen","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/nbdi.2001.0453","article-title":"Low brain histamine content affects ethanol-induced motor impairment","volume":"9","author":"Lintunen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2010.05.003","article-title":"N-methyl-d-aspartic acid receptors are altered by stress and alcohol in Wistar\u2013Kyoto rat brain","volume":"169","author":"Lei","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2012.04.021","article-title":"Brain-derived neurotrophic factor expression after acute administration of ethanol","volume":"687","author":"Raivio","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0250","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1530-0277.2009.00916.x","article-title":"Ethanol-sensitive brain regions in rat and mouse: a cartographic review, using immediate early gene expression","volume":"33","author":"Vilpoux","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0255","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0091-3057(91)90116-J","article-title":"Pentylenetetrazole can induce a conditioned place preference","volume":"40","author":"Gauvin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0260","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.neuroscience.2009.11.058","article-title":"Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats","volume":"165","author":"Kitanaka","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300860","article-title":"Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0270","doi-asserted-by":"crossref","first-page":"PL297","DOI":"10.1016\/S0024-3205(00)00548-8","article-title":"Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice","volume":"66","author":"Vohora","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-3057(99)00242-7","article-title":"Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine","volume":"65","author":"Carlson","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1254\/jjp.43.277","article-title":"Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay","volume":"43","author":"Kubo","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248413501017","article-title":"New and emerging drug molecules against obesity","volume":"19","author":"George","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1533317513488925","article-title":"The neglected role of histamine in Alzheimer's disease","volume":"28","author":"Naddafi","year":"2013","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnsys.2012.00072","article-title":"Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse","volume":"6","author":"Vohora","year":"2012","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/157488912800673182","article-title":"Novel medication targets for the treatment of alcoholism: preclinical studies","volume":"7","author":"Rezvani","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(25)10340-6","article-title":"S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist","volume":"263","author":"Garbarg","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0310","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1471-4159.1989.tb09237.x","article-title":"Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain","volume":"53","author":"Garbarg","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0315","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)37840-1","article-title":"Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist","volume":"287","author":"Ligneau","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0320","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703712","article-title":"Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain","volume":"131","author":"Ligneau","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0325","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0022-3565(25)22816-6","article-title":"[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors","volume":"271","author":"Ligneau","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0330","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/jm050170s","article-title":"Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles","volume":"48","author":"Schlotter","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0335","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1021\/cr0101510","article-title":"Bioorganometallic chemistry of ferrocene","volume":"104","author":"van Staveren","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0340","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00259-002-0900-8","article-title":"Current use and future potential of organometallic radiopharmaceuticals","volume":"29","author":"Schibli","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0345","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.bmcl.2009.02.110","article-title":"Fluorinated non-imidazole histamine H3 receptor antagonists","volume":"19","author":"Isensee","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0928-0987(01)00106-3","article-title":"Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists","volume":"13","author":"Meier","year":"2001","journal-title":"European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0355","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/ml300383n","article-title":"Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand","volume":"4","author":"Tomasch","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0360","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cmdc.200600270","article-title":"Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands","volume":"2","author":"Amon","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.physbeh.2015.07.012_bb0365","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0968-0896(01)00286-3","article-title":"Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists","volume":"10","author":"Barbaro","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0370","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0960-894X(01)00772-7","article-title":"Alpha(1)-adrenoceptor antagonists. Rational design, synthesis and biological evaluation of new trazodone-like compounds","volume":"12","author":"Betti","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.physbeh.2015.07.012_bb0375","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.bmc.2008.04.058","article-title":"Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin","volume":"16","author":"Handzlik","year":"2008","journal-title":"Bioorg. Med. Chem."}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:59:11Z","timestamp":1748491151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938415300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":75,"alternative-id":["S0031938415300251"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.07.012","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}